In summary, we identified that the signature (FOXM1 and cg00044170) and FOXM1 may be valuable for early diagnosis of ccRCC and OS prognosis for pT3 patients with distant metastasis respectively. This evidence concerns the gene FOXM1 and nonpapillary renal cell carcinoma.